Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials

Double-Blind, Placebo-Controlled Trial of Ketamine Therapy in Treatment-Resistant Depression (TRD)

To see complete record on, please visit this link

Id: NCT01920555

Organisation Name: Massachusetts General Hospital

Overal Status: Completed

Start Date: December 2014

Last Update: June 19, 2018

Lead Sponsor: Massachusetts General Hospital

Brief Summary: This study is looking at the efficacy, durability, safety, and tolerability of multiple single doses of Ketamine vs. active placebo for treating patients with treatment resistant depression who are taking an antidepressant that is not working for them.

  • Treatment Resistant Depression

Total execution time in seconds: 0.38338899612427